Education
About Us
Working with TipRanks
Follow Us
Elanco Animal Health (ELAN)
NYSE:ELAN
Total Valuation
Elanco Animal Health has a market cap or net worth of $11.41B. The enterprise value is $14.88B.
Market Cap$11.41B
Enterprise Value$14.88B
Share Statistics
Elanco Animal Health has 497,168,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding497,168,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Elanco Animal Health’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is 2.13%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)2.13%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee523.89K
Profits Per Employee-25.78K
Employee Count9,000
Asset Turnover0.35
Inventory Turnover1.53
Valuation Ratios
The current PE Ratio of Elanco Animal Health is ―. Elanco Animal Health’s PEG ratio is 0.29.
PE Ratio―
PS Ratio2.38
PB Ratio1.72
Price to Fair Value1.72
Price to FCF39.55
Price to Operating Cash Flow20.36
PEG Ratio0.29
Income Statement
In the last 12 months, Elanco Animal Health had revenue of 4.71B and earned -232.00M in profits. Earnings per share was -0.47.
Revenue4.71B
Gross Profit2.05B
Operating Income252.00M
Pretax Income-224.00M
Net Income-232.00M
EBITDA676.00M
Earnings Per Share (EPS)-0.47
Cash Flow
In the last 12 months, operating cash flow was 560.00M and capital expenditures -276.00M, giving a free cash flow of 284.00M billion.
Operating Cash Flow560.00M
Free Cash Flow284.00M
Free Cash Flow per Share0.57
Dividends & Yields
Elanco Animal Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.38
52-Week Price Change115.60%
50-Day Moving Average24.43
200-Day Moving Average19.90
Relative Strength Index (RSI)38.28
Average Volume (3m)4.29M
Important Dates
Elanco Animal Health upcoming earnings date is May 13, 2026, Before Open (Confirmed).
Last Earnings DateFeb 24, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
Elanco Animal Health as a current ratio of 2.17, with Debt / Equity ratio of 61.36%
Current Ratio2.17
Quick Ratio1.08
Debt to Market Cap0.36
Net Debt to EBITDA5.14
Interest Coverage Ratio1.15
Taxes
In the past 12 months, Elanco Animal Health has paid 8.00M in taxes.
Income Tax8.00M
Effective Tax Rate-0.04
Enterprise Valuation
Elanco Animal Health EV to EBITDA ratio is 21.75, with an EV/FCF ratio of 51.78.
EV to Sales3.12
EV to EBITDA21.75
EV to Free Cash Flow51.78
EV to Operating Cash Flow26.26
Balance Sheet
Elanco Animal Health has $545.00M in cash and marketable securities with $4.02B in debt, giving a net cash position of -$3.47B billion.
Cash & Marketable Securities$545.00M
Total Debt$4.02B
Net Cash-$3.47B
Net Cash Per Share-$6.98
Tangible Book Value Per Share-$3.30
Margins
Gross margin is 46.45%, with operating margin of 5.34%, and net profit margin of -4.92%.
Gross Margin46.45%
Operating Margin5.34%
Pretax Margin-4.75%
Net Profit Margin-4.92%
EBITDA Margin14.34%
EBIT Margin-0.08%
Analyst Forecast
The average price target for Elanco Animal Health is $29.40, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$29.40
Price Target Upside28.16% Upside
Analyst ConsensusStrong Buy
Analyst Count11
Revenue Growth Forecast3.08%
EPS Growth Forecast-82.39%